With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Impact of STAG2 loss on DNA Damage and Immunobiology in Ewing sarcoma||University of Pittsburgh / Kelly Bailey, MD, PhD||Innovation Grants||2022||Pennsylvania|
|Developmental origins of leukemia in Down Syndrome||University of Rochester / James Palis, MD & Laurie Steiner, MD||Innovation Grants||2022||New York|
|Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy||University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD||Innovation Grants||2022||Wisconsin|
|Blocking the Evil Messenger in MYCN-driven High-risk Neuroblastoma||Boston University / Hui Feng, Md, PhD||Innovation Grants||2022||Massachusetts|
|Characterizing the Developmental Context of Pediatric Leukemia||Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD||'A' Award Grants||2022||New York|
|Developing Novel Transcription Factor PROTACs to Disrupt the HMGA1 Epigenome in Relapsed Leukemia||Icahn School of Medicine at Mount Sinai / Linda Resar, MD and Jian Jin, PhD||Innovation Grants||2022||New York|
|Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants||University of Washington, Seattle / Abbye McEwen, MD, PhD||RUNX1 Early Career Investigator Grants||2022||Washington|
|Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations||The Regents of the University of Michigan / Jolanta Grembecka, PhD||Reach Grants||2022||Michigan|
|Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system||The Regents of the University of Michigan / Sriram Venneti, MD/PhD||R Accelerated Award Grants||2022||Michigan|
|Mechanistic and Therapeutic Development of ATM as a Tumor Cell Selective Target for Radiosensitization in H3K27M DMG||The Regents of the University of Michigan / Meredith Morgan, PhD & Daniel Wahl, MD/PhD||Reach Grants||2022||Michigan|